We propose that the development of mitochondrial dysfunction and IR, secondary to muscular PPARG downregulation by BC, creates an environment that facilitates the development of muscle fatigue through several mechanisms, including decreased mitochondrial ATP production as well as dysregulated glucose and lipid metabolism. This evidence concerns the gene PPARG and breast cancer.